JOSE SIMO: Open Payments
NPI 1952968026 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 14 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $935 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $149 |
| PFIZER INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerecis SurgiClose, Kerendia, VERQUVO, LEQVIO, ONPATTRO, ELIQUIS, VYNDAQEL, BodyGuardian.
Industry payments across FL — which companies pay providers there.
